Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)
International Journal of STD & AIDS · 2024
DOI: 10.1177/09564624231215977 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2024. Verfasst von Charlotte O'Halloran und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs (HIV), MSD (UK) Limited, London, UK. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV-1, HIV Infections, Pyridones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Merck Sharp and Dohme UK.
Abstract (Originalsprache)
Background
Doravirine is a non-nucleoside reverse transcriptase inhibitor recommended for the treatment of virologically suppressed and treatment naïve people living with HIV. The DRIVE-REAL study aimed to describe the characteristics, treatment patterns, and virological outcomes of doravirine users in a real-world cohort in the UK.
Methods
A retrospective, observational, multi-centre chart review was conducted for 300 adults living with HIV initiating doravirine-containing antiretroviral therapy.
Results
At baseline 83% of individuals were male, 45% aged ≥50 years, 65% white ethnicity. Median time since HIV diagnosis was 12 years. 96% were antiretroviral therapy-experienced, 87% had a HIV viral load
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Affairs (HIV), MSD (UK) Limited, London, UK.
- HIV and Sexual Health, Brighton & Sussex Medical School and University Hospitals Sussex NHS Trust, Brighton, UK.
- St Stephen's Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
- College London and Mortimer Market Centre, Centre for Clinical Research in Infection and Sexual Health University, London, UK.
- Adelphi Real World (ARW), Bollington, UK.
- Imperial College London, London, UK.
ORCID-Profile: Sophie Ross, William Hickey
Förderung
- Merck Sharp and Dohme UK
Zitieren
APA
O'Halloran, C., Gilleece, Y., Leung, S., Canuto, V., McAlpine, C., Ross, S., Norcross, C., Gaffney, S., Siani, N., Hickey, W., Moore, A., Rajkovic-Hooley, O., & Milinkovic, A. (2024). Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL). International Journal of STD & AIDS. https://doi.org/10.1177/09564624231215977
Vancouver
O'Halloran C, Gilleece Y, Leung S, Canuto V, McAlpine C, Ross S, et al. Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL). International Journal of STD & AIDS. 2024. doi:10.1177/09564624231215977
BibTeX
@article{OHalloran2024,
author = {O'Halloran, Charlotte and Gilleece, Yvonne and Leung, Suki and Canuto, Veronica and McAlpine, Connor and Ross, Sophie and Norcross, Claire and Gaffney, Stuart and Siani, Nipur and Hickey, William and Moore, Adam and Rajkovic-Hooley, Olivera and Milinkovic, Ana},
title = {Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)},
journal = {International Journal of STD & AIDS},
year = {2024},
doi = {10.1177/09564624231215977}
}
EUVIMED